OQRO

Feed News

Explore

Insider trades Fund moves Congressional trades Federal contracts Screener

Yours

Watchlist Alerts Saved Ask Claude or ChatGPT

Create a free account Sign in

OQRO

Search/

Loading…

Officer exercised or converted 2,105 CYTK derivative securities | OQRO

Home
Insider trades
Cytokinetics
Officer exercised or converted 2,105 CYTK derivative securities

Insider trades

Insider trade

Officer exercised or converted 2,105 CYTK derivative securities

Traded Oct 21, 2025 · Filed Oct 21, 2025

CYTCytokineticsCYTK

2,105
Shares · @ $10.60

Why it stands out

Derivative exercise or conversion — not an open-market buy.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Oct 21, 2025
Reporting period: Not applicable
Filed with the SEC: Oct 21, 2025

OfficerOption exercise

Context

Classification

option exercise

Code M — exercise or conversion of a derivative security

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001061983-25-000025

Ask Claude or ChatGPT about these filings. Connect OQRO in a minute, then ask things like “which insiders bought this week?”

Filed / recorded

Oct 21, 2025, 10:18 PM UTC

Added to OQRO

Oct 6, 2026, 7:14 PM UTC

Parser

form4-xml-v2

Data quality

Verified: identifiers matched exactly

Issuer

CYTOKINETICS INC

Issuer CIK

1061983

Ticker

CYTK

Reporting person

Fady Ibraham Malik

Relationship

Officer

Officer title

EVP Research & Development

Security

Common Stock

Table

Non-derivative (Table I)

Transaction date

Oct 21, 2025

Transaction code

Shares / units

2,105

Price per share

$10.60

Acquired / disposed

Acquired (A)

Shares owned after

142,715

Ownership form

Direct

Amendment

Around the same time

B Lynne Parshall (Director) sold ~$324K of Cytokinetics

Automatic saleFiled 11mo ago

Fady Ibraham MalikEVP Research & Development

Filed 11mo ago

2,200Shares · @ $10.60

Traded Nov 18, 2025 · filed the same day

Derivative exercise or conversion — not an open-market buy.

More Official record

Fady Ibraham Malik (EVP Research & Development) sold ~$146K of Cytokinetics

Automatic saleFiled 11mo ago